Matches in Wikidata for { <http://www.wikidata.org/entity/Q88122757> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- Q88122757 description "article scientifique publié en 2014" @default.
- Q88122757 description "artículu científicu espublizáu en xunu de 2014" @default.
- Q88122757 description "im Juni 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q88122757 description "scientific article published on 18 June 2014" @default.
- Q88122757 description "wetenschappelijk artikel" @default.
- Q88122757 description "наукова стаття, опублікована в червні 2014" @default.
- Q88122757 description "գիտական հոդված հրատարակված 2014 թվականի հունիսի 18-ին" @default.
- Q88122757 name "A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with i" @default.
- Q88122757 name "A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with i" @default.
- Q88122757 type Item @default.
- Q88122757 label "A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with i" @default.
- Q88122757 label "A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with i" @default.
- Q88122757 prefLabel "A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with i" @default.
- Q88122757 prefLabel "A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with i" @default.
- Q88122757 P1433 Q88122757-D797DFFC-340D-4838-810F-44CED7E4B138 @default.
- Q88122757 P1476 Q88122757-3E53741A-E87E-4837-929A-E1BD16A1AAAC @default.
- Q88122757 P2093 Q88122757-14F57B67-2179-4E02-BF25-BFE181EBED54 @default.
- Q88122757 P2093 Q88122757-21706927-1FEB-4970-9D8E-18044609DDB4 @default.
- Q88122757 P2093 Q88122757-288C6F10-7104-4F52-A219-88E233A9AC1C @default.
- Q88122757 P2093 Q88122757-2E34F6E7-B44F-4316-A5F1-98503323A7D4 @default.
- Q88122757 P2093 Q88122757-70E01C42-5AFD-41E8-A312-D161BB000A3A @default.
- Q88122757 P2093 Q88122757-7978023B-0EB1-40B2-9D42-436D790F7F45 @default.
- Q88122757 P2093 Q88122757-7EEE0BA9-1CDC-4292-B677-54DD82B1BE4E @default.
- Q88122757 P2093 Q88122757-ADBC4CC7-A67A-4F22-A8D7-B258425FAC45 @default.
- Q88122757 P2093 Q88122757-B5084D2C-8714-482B-B233-3B33C61CE0E8 @default.
- Q88122757 P2093 Q88122757-C5CAE62F-0E76-4A56-A2E9-362DB64CF6C3 @default.
- Q88122757 P2093 Q88122757-CBFA81C9-59E6-4D9B-BFAC-11A4B05DFE0E @default.
- Q88122757 P304 Q88122757-83C1563A-AC6F-487E-ACCB-C724D2476FC5 @default.
- Q88122757 P31 Q88122757-0F9BA7FA-0199-437A-9A77-BC1BF17A0E01 @default.
- Q88122757 P356 Q88122757-CBE53335-D658-474F-A418-8FC041E0D97C @default.
- Q88122757 P433 Q88122757-07639B78-D273-4100-AA79-D6962D3EDA89 @default.
- Q88122757 P478 Q88122757-4F3AB9A5-532F-44C2-824B-8DCE54151700 @default.
- Q88122757 P50 Q88122757-8A7425E5-8D34-4208-94A2-37899D6908A4 @default.
- Q88122757 P577 Q88122757-1D377DD9-4613-4647-AB1D-DFACBEA518A6 @default.
- Q88122757 P698 Q88122757-8473367C-3385-48AF-B9A2-E2BB29EA312F @default.
- Q88122757 P921 Q88122757-4FAE37C5-C22F-44C0-B319-7A00607CEEAC @default.
- Q88122757 P921 Q88122757-54A4B724-40B0-4E09-9540-9D5BD402B5BB @default.
- Q88122757 P921 Q88122757-64B76820-16BE-45CF-A851-B259C7C567FB @default.
- Q88122757 P356 J.BCMD.2014.05.004 @default.
- Q88122757 P698 24950666 @default.
- Q88122757 P1433 Q15758051 @default.
- Q88122757 P1476 "A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase" @default.
- Q88122757 P2093 "Ari Zimran" @default.
- Q88122757 P2093 "Dominick J Amato" @default.
- Q88122757 P2093 "Ee Shien Tan" @default.
- Q88122757 P2093 "Einat Brill-Almon" @default.
- Q88122757 P2093 "Eugen Mengel" @default.
- Q88122757 P2093 "Hanna Rosenbaum" @default.
- Q88122757 P2093 "Jeffrey Szer" @default.
- Q88122757 P2093 "Milan Petakov" @default.
- Q88122757 P2093 "Patrick B Deegan" @default.
- Q88122757 P2093 "Pilar Giraldo" @default.
- Q88122757 P2093 "Raul Chertkoff" @default.
- Q88122757 P304 "253-260" @default.
- Q88122757 P31 Q13442814 @default.
- Q88122757 P356 "10.1016/J.BCMD.2014.05.004" @default.
- Q88122757 P433 "4" @default.
- Q88122757 P478 "53" @default.
- Q88122757 P50 Q88122753 @default.
- Q88122757 P577 "2014-06-18T00:00:00Z" @default.
- Q88122757 P698 "24950666" @default.
- Q88122757 P921 Q42824827 @default.
- Q88122757 P921 Q6934595 @default.
- Q88122757 P921 Q861645 @default.